Most cited papers from EyeRx Research (United States)
What are the most cited papers from EyeRx Research (United States)?
The most cited paper from EyeRx Research (United States) is "Efficacy of a Phosphorodiamidate Morpholino Oligomer Antisense Compound in the Inhibition of Corneal Transplant Rejection in a Rat Cornea Transplant Model" (Alireza Hosseini, Frank A. Lattanzio, Sandeep S. Samudre et al., 2011), with 19 citations. Next come "A Comprehensive System for Pterygium Classification" (16) and "Extended Treatment With Lacritin, a Novel Tear Glycoprotein, Stimulates Tear Production in Rabbits" (0).
Showing 3 of 3 papers. Every paper is listed.
| # | Paper | ||
|---|---|---|---|
| 1 | Efficacy of a Phosphorodiamidate Morpholino Oligomer Antisense Compound in the Inhibition of Corneal Transplant Rejection in a Rat Cornea Transplant Model Alireza Hosseini, Frank A. Lattanzio, Sandeep S. Samudre et al. · Journal of Ocular Pharmacology and Therapeutics | 7 Dec 2011 | 19 |
| 2 | A Comprehensive System for Pterygium Classification Samuel Johnston, Patricia B. Williams, John D. Sheppard · Investigative Ophthalmology & Visual Science | May 2004 | 16 |
| 3 | Extended Treatment With Lacritin, a Novel Tear Glycoprotein, Stimulates Tear Production in Rabbits Arielle R. Spitze, Jack Sheppard, Patricia B. Williams et al. · Investigative Ophthalmology & Visual Science | May 2006 | 0 |
Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.